We have shown that the CDH2 gene was most often mutated in anaplastic astrocytoma (grade 3, 4.08%), while amplifications were present in a smaller percentage of diffuse gliomas and GBMs in which deep deletions were also recorded. Here, CDH2 is linked to anaplastic astrocytoma.